Stocks Overview

LAST PRICE
10.3199
TODAY'S CHANGE (%)
Trending Down-0.6801 (-6.1827%)

Bid / Lots
10.3000/ 7
Ask / Lots
10.3200/ 7
Open / Previous Close
10.8300 / 11.0000
Day Range
Low 10.1600
High 10.9500
52 Week Range
Low 2.5700
High 13.8500
Volume
918,562
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 11
Time	Volume	CRMD
09:32 ET	47277	10.75
09:33 ET	800	10.85
09:35 ET	3257	10.76
09:37 ET	12468	10.8399
09:39 ET	5404	10.85
09:42 ET	2300	10.9
09:44 ET	8400	10.83
09:46 ET	1050	10.77
09:48 ET	2150	10.82
09:50 ET	12147	10.79
09:51 ET	8400	10.845
09:53 ET	600	10.8852
09:55 ET	720	10.8225
09:57 ET	2140	10.77
10:00 ET	5837	10.775
10:02 ET	100	10.76
10:04 ET	1500	10.77
10:06 ET	1627	10.76
10:08 ET	33212	10.71
10:09 ET	5908	10.7173
10:11 ET	14569	10.71
10:13 ET	100	10.71
10:15 ET	3668	10.695
10:18 ET	927	10.6953
10:20 ET	3200	10.7186
10:22 ET	4002	10.725
10:24 ET	1100	10.7124
10:26 ET	4752	10.6943
10:27 ET	6000	10.72
10:29 ET	1519	10.715
10:31 ET	5722	10.76
10:33 ET	2319	10.6902
10:36 ET	5142	10.755
10:38 ET	9730	10.7
10:40 ET	1944	10.745
10:42 ET	2591	10.76
10:44 ET	9538	10.7
10:45 ET	800	10.69
10:47 ET	1150	10.68
10:49 ET	700	10.7
10:51 ET	10167	10.68
10:54 ET	1400	10.6489
10:56 ET	100	10.63
10:58 ET	12962	10.57
11:00 ET	5633	10.62
11:02 ET	200	10.63
11:03 ET	3768	10.64
11:05 ET	2976	10.64
11:07 ET	400	10.65
11:09 ET	700	10.645
11:12 ET	20229	10.595
11:14 ET	4095	10.65
11:16 ET	105319	10.67
11:18 ET	1325	10.69
11:20 ET	2294	10.66
11:21 ET	9607	10.6
11:23 ET	1100	10.6
11:25 ET	3300	10.63
11:27 ET	2099	10.63
11:30 ET	1000	10.64
11:32 ET	200	10.67
11:34 ET	990	10.665
11:36 ET	1799	10.655
11:38 ET	25442	10.525
11:39 ET	953	10.53
11:41 ET	500	10.53
11:43 ET	500	10.5462
11:45 ET	1100	10.53
11:48 ET	15382	10.47
11:50 ET	656	10.4
11:52 ET	6666	10.45
11:54 ET	700	10.465
11:56 ET	310	10.48
11:57 ET	150	10.465
11:59 ET	5960	10.505
12:01 ET	2261	10.5
12:03 ET	6323	10.43
12:06 ET	100	10.435
12:08 ET	1054	10.44
12:10 ET	4092	10.44
12:12 ET	1241	10.46
12:14 ET	1550	10.4585
12:15 ET	1000	10.465
12:17 ET	300	10.47
12:19 ET	511	10.47
12:21 ET	700	10.475
12:24 ET	2981	10.49
12:26 ET	2204	10.49
12:28 ET	6166	10.5
12:30 ET	2191	10.49
12:32 ET	900	10.4542
12:33 ET	200	10.43
12:35 ET	800	10.45
12:37 ET	1412	10.42
12:39 ET	6090	10.395
12:42 ET	292	10.38
12:44 ET	5301	10.332
12:46 ET	4862	10.3343
12:48 ET	8971	10.3
12:50 ET	10403	10.3307
12:53 ET	361	10.325
12:57 ET	1400	10.27
01:00 ET	4647	10.26
01:02 ET	900	10.26
01:04 ET	6257	10.24
01:06 ET	4987	10.224
01:08 ET	862	10.239
01:09 ET	1977	10.235
01:11 ET	1588	10.25
01:13 ET	900	10.2443
01:15 ET	590	10.235
01:18 ET	2581	10.22
01:20 ET	10317	10.23
01:22 ET	700	10.25
01:24 ET	400	10.245
01:26 ET	1100	10.22
01:27 ET	645	10.1892
01:29 ET	878	10.21
01:31 ET	1999	10.21
01:33 ET	889	10.2114
01:36 ET	340	10.226
01:38 ET	7097	10.172
01:42 ET	4859	10.19
01:44 ET	700	10.175
01:45 ET	943	10.2
01:47 ET	4068	10.211
01:49 ET	3492	10.22
01:51 ET	9676	10.225
01:54 ET	450	10.225
01:56 ET	2999	10.195
01:58 ET	1064	10.23
02:00 ET	1000	10.215
02:02 ET	500	10.21
02:03 ET	511	10.2
02:05 ET	7973	10.205
02:07 ET	3614	10.24
02:09 ET	4009	10.29
02:12 ET	1400	10.27
02:14 ET	9422	10.3446
02:16 ET	500	10.31
02:18 ET	13467	10.27
02:20 ET	2969	10.32
02:23 ET	2281	10.31
02:25 ET	1191	10.29
02:27 ET	400	10.29
02:30 ET	5213	10.31
02:32 ET	1200	10.31
02:34 ET	1755	10.315
02:36 ET	427	10.315
02:38 ET	700	10.315
02:39 ET	1385	10.315
02:41 ET	2020	10.3599
02:43 ET	1624	10.37
02:45 ET	100	10.35
03:17 ET	300	10.36
03:19 ET	300	10.36
03:21 ET	14147	10.34
03:24 ET	1100	10.335
03:26 ET	3440	10.32
03:28 ET	800	10.33
03:32 ET	2000	10.34
03:33 ET	792	10.358
03:35 ET	1157	10.3451
03:37 ET	1889	10.36
03:39 ET	2906	10.385
03:42 ET	2007	10.38
03:44 ET	5501	10.33
03:46 ET	2472	10.34
03:48 ET	5293	10.32
03:50 ET	3273	10.3199

Data delayed at least 15 minutes.

Nov 4, 2024
- CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones
  8:30AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
- DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
  6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 30, 2024
- DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
  11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
- *DJ CorMedix 3Q Loss/Shr 5c >CRMD, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
- CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCRMD CorMedix Inc	667.4M	-12.9x	---
United StatesZVRA Zevra Therapeutics Inc	482.0M	-5.1x	---
United StatesELTP Elite Pharmaceuticals Inc	553.0M	29.1x	---
United StatesCPLFY Cipla Ltd	14.3B	0.0x	---
United StatesETON Eton Pharmaceuticals Inc	270.2M	-46.3x	---
United StatesIXHL Incannex Healthcare Inc	41.3M	-1.9x	---
As of 2024-11-15

CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.

Contact Information

Headquarters: 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
Phone: 908-517-9500
Fax: 302-636-5454

Executives

Independent Chairman of the Board: Myron Kaplan
Chief Executive Officer, Director: Joseph Todisco
Chief Financial Officer, Executive Vice President: Matthew David
Executive Vice President, Chief Clinical Strategy and Operations Officer: Elizabeth Massonhurlburt
Executive Vice President, Chief Legal Officer and Corporate Secretary: Beth Kaufman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$667.4M
Revenue (TTM)	$12.3M
Shares Outstanding	60.7M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.58
EPS	$-0.80
Book Value	$1.28
P/E Ratio	-12.9x
Price/Sales (TTM)	54.4
Price/Cash Flow (TTM)	---
Operating Margin	-415.59%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

CorMedix Inc
NASDAQ:CRMDUnited States

Search Criteria

Charts

Recent News

Nov 4, 2024

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones

Oct 31, 2024

DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones

Oct 30, 2024

DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones

*DJ CorMedix 3Q Loss/Shr 5c >CRMD, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

Pharmaceuticals - Generic & Specialty Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar